This module enables investors to look at Edwards Lifesciences various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 560.2 M, Cost of Revenue of 744.5 M or Earning Before Interest and Taxes EBIT of 735.1 M, but also many exotic indicators such as Interest Coverage of 83.0439, Long Term Debt to Equity of 0.2914 or Calculated Tax Rate of 22.793. This module is a perfect complement to use when analyzing Edwards Lifesciences Valuation or Volatility. It can also complement various Edwards Lifesciences Technical models. Additionally see analysis of Edwards Lifesciences Correlation with competitors.
Showing smoothed Price to Sales Ratio of Edwards Lifesciences Corporation with missing and latest data points interpolated. Price to Sales Ratio is figured by comparing Edwards Lifesciences stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Edwards Lifesciences sales, a figure that is much harder to manipulate than other Edwards Lifesciences Corporation multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. An alternative calculation method to [PS], that measures the ratio between a company's Adjusted Share Price and it's Sales per Share.
|10 Years Trend|
Compare to Other EquitiesAll Fundamental Data
Edwards Lifesciences Price to Sales Ratio Over Time